Retrospective study on trilostane titration dose treatment in dogs with terminal stage of hyperadrenocorticism
Hyperadrenocorticism (HAC) in dogs is routinely treated with trilostane single-dose (CTG) which is reported to cause adverse reactions. The current retrospective study of several dogs with terminal stage of HAC aimed to compare the clinical, hematological, and biochemical effects of trilostane titra...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Ss.Cyril and Methodius University, Skopje
2024-03-01
|
| Schriftenreihe: | Macedonian Veterinary Review |
| Schlagworte: | |
| Online-Zugang: | https://macvetrev.mk/LoadArticleContent?DOI=10.2478_macvetrev_2024_0016 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|